Option Care Health just smashed Q2 earnings with $1.44B in revenue—beating estimates—and quietly boosted its full-year forecast. Acute care is soaring with high-single-digit growth, while chronic care is stabilizing after earlier hiccups. The company’s doubling down on AI and tech to streamline operations, all while keeping costs under control and prioritizing local, quality care. Ahead, they’re expanding rare drug access and driving sequential growth through productivity gains and a rebound in chronic therapies. Markets are cheering—they’re executing their strategy flawlessly.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
